1906 Bliss Cannabis Pills

Description

1. Product Overview
The 1906 Bliss Cannabis Pills are a precision-dosed, orally ingestible cannabis formulation engineered for rapid systemic delivery of mood-enhancing and anxiolytic effects. Their primary industrial use is as a raw finished-good unit for B2B distribution channels, including pharmaceutical adjunct supply chains, high-volume wellness retailers, and medical cannabis formularies. The key value proposition lies in their proprietary “Go Quick” technology, enabling onset in approximately 15–20 minutes—a strategic differentiator against standard edibles. This product is strategically important in markets shifting from combustion-based consumption to predictable, smoke-free, dose-accurate alternatives.

2. Key Specifications & Technical Characteristics

• Chemical composition: Full-spectrum hemp-derived cannabis extract, ≤0.3% delta-9 THC by dry weight (2018 Farm Bill compliant) + 10mg CBD / 5mg THC (ratio 2:1) + proprietary botanical terpene blend (limonene, linalool, beta-caryophyllene)

• Purity level / grade: Pharmaceutical-grade extraction (CO2 method), passing heavy metals, residual solvents, microbial, and mycotoxin screens to USP <561> standards

• Physical characteristics: Round, film-coated mini-tablet; 8mm diameter; beige to light brown; weight approx. 380mg per pill; <0.5% moisture content

• Packaging options: Industrial bulk: 5kg foil-lined HDPE pails (≈13,150 pills) or 20kg master cartons with desiccant packs

• Shelf life: 24 months from manufacture when stored at 15–25°C, <60% RH, in original sealed packaging

3. Core Industrial Applications

• Primary industries: Medical cannabis distributors, corporate wellness programs, hospitality group purchasing organizations (GPOs), and specialty supplement logistics firms

• Specific operational use cases:

  • Mid-day stress mitigation – workplace wellness dispensaries servicing shift-based employees

  • Pre-sleep transition – hospitality chains offering microdosed relaxation alternatives to alcohol minibars

  • Anxiety-adjunct protocols – telehealth platforms bundling predictable-dose cannabis with behavioral health sessions

• Performance advantage vs. alternatives: Standard edibles require 45–90 min onset due to first-pass liver metabolism. 1906 Bliss uses self-emulsifying excipients (medium-chain triglycerides + lecithin) accelerating buccal and gastric absorption, achieving Tmax at 30 min vs. 90–120 min for conventional gummies. This reduces redosing risk and improves patient/consumer compliance.

• Cost advantage: Higher per-unit manufacturing cost offset by 40% lower returns due to unpredictable onset, and 30% reduction in required SKUs for retailers (single product replaces multiple “fast/slow” lines).

4. Competitive Advantages

• Quality consistency: Batch-to-batch cannabinoid content variation ≤±3% (industry standard ±10–15%); third-party COA with ISO/IEC 17025 lab verification included per shipment.

• Supply reliability: Vertically integrated cultivation-to-packaging; 98.7% on-time in-full (OTIF) rate over trailing 12 months; safety stock held in two regional DCs.

• Logistics capability: Ambient-temperature shipping (no cold chain required) reduces freight cost by 18–22% vs. cannabis beverages or chocolates.

• Price competitiveness: Tiered pricing down to $0.18 per mg of active cannabinoid for contract volumes ≥500kg monthly (landed duty-paid).

• Sustainability: 100% plastic-neutral packaging via rePurpose Global; all botanical waste composted to OMRI-listed soil amendment.

• Technical documentation: Full Drug Master File (DMF) access for licensed buyers; stability study data; regulatory compliance dossier for 14 jurisdictions.

5. Commercial & Supply Information

• Minimum order quantity (MOQ): BULK 20MT (twenty metric tons) per purchase order, split across up to two SKUs/variants allowed.

• Loading capacity: 20MT per 20-foot dry container (palletized: 20 EUR pallets, 1,000kg each). Max 24MT per 40-foot high cube container with floor load.